<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for REGN</title>
    <link />
    <description>Headlines for Regeneron Pharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Meet the 4 Newest Members of the S&amp;P 500</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/25/meet-the-4-newest-members-of-the-sp/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 25 May 2013 11:31:00 GMT</pubDate>
    </item>
    <item>
      <title>Today’s 3 Worst Stocks</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/23/todays-3-worst-stocks-96/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 23 May 2013 19:06:00 GMT</pubDate>
    </item>
    <item>
      <title>Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Laggard</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11932976/1/regeneron-pharmaceuticals-inc-regn-todays-featured-drugs-laggard.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 23 May 2013 17:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Market Close Report: NASDAQ Composite index closes at 3,459.42 down -3.88 points</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/market-close-report-nasdaq-composite-index-closes-at-345942-down-388-points-cm248342.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Thu, 23 May 2013 16:45:14 GMT</pubDate>
    </item>
    <item>
      <title>Amgen Stock Checkup for May</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/23/amgen-stock-checkup-for-may/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 23 May 2013 14:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi/REGN's Dupilumab Data Published - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99956/sanofi-regns-dupilumab-data-published.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 22 May 2013 21:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Regeneron Shareholders Watching Optina Trial Closely</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1454651-regeneron-shareholders-watching-optina-trial-closely.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 22 May 2013 15:56:43 GMT</pubDate>
    </item>
    <item>
      <title>Regeneron and Sanofi: An Unstoppable Biotech Duo?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/21/regeneron-and-sanofi-an-unstoppable-biotech-duo/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 21 May 2013 18:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Regeneron-Sanofi Asthma Drug Shows Promising Early Results</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130521-000313&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Tue, 21 May 2013 12:15:59 GMT</pubDate>
    </item>
    <item>
      <title>Regeneron Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-20-2013 10:00 AM</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1447681-regeneron-pharmaceuticals-inc-presents-at-ubs-global-healthcare-conference-may-20-2013-10-00-am.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 20 May 2013 13:50:07 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Underperforming Today In The Drugs Industry</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11928285/1/5-stocks-underperforming-today-in-the-drugs-industry.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 20 May 2013 13:04:00 GMT</pubDate>
    </item>
    <item>
      <title>Regeneron Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (REGN)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11927885/1/regeneron-pharmaceuticals-inc-stock-buy-recommendation-reiterated-regn.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 20 May 2013 10:01:00 GMT</pubDate>
    </item>
    <item>
      <title>2 Healthcare Companies And 1 Consumer Goods Company With Recent Intensive Insider Selling</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1446841-2-healthcare-companies-and-1-consumer-goods-company-with-recent-intensive-insider-selling.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 20 May 2013 09:51:08 GMT</pubDate>
    </item>
    <item>
      <title>Will ASCO Unlock Big Value in This Cancer Drug Class?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/will-asco-unlock-big-value-in-this-cancer-drug-cla/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 14:30:00 GMT</pubDate>
    </item>
    <item>
      <title>S&amp;P 500 Stocks Farthest Above 50-DMAs</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1439871-s-p-500-stocks-farthest-above-50-dmas.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 16 May 2013 09:19:35 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi and Regeneron's Latest Partnership</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/15/sanofi-and-regenerons-latest-partnership-4/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 15 May 2013 21:13:00 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi/REGN Commence Enrollment - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99496/sanofi-regn-commence-enrollment.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 15 May 2013 17:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Laggard</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11925038/1/regeneron-pharmaceuticals-inc-regn-todays-featured-drugs-laggard.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 15 May 2013 17:01:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Stocks Underperforming Today In The Drugs Industry</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11924650/1/3-stocks-underperforming-today-in-the-drugs-industry.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 15 May 2013 13:03:00 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi, Regeneron Announce Patient Enrollment in Two Phase 3 Sarilumab Trials for Rheumatoid Arthrit</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/05/3590685/sanofi-regeneron-announce-patient-enrollment-in-two-phase-3-sarilumab-tr.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 15 May 2013 05:55:06 GMT</pubDate>
    </item>
  </channel>
</rss>
